{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:01:23Z","timestamp":1762498883740,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clnesp.2021.01.037","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T02:21:38Z","timestamp":1612664498000},"page":"212-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Fibromyalgia associated with Chagas' disease treated with nutraceuticals"],"prefix":"10.1016","volume":"42","author":[{"given":"Joz\u00e9lio Freire","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10115","key":"10.1016\/j.clnesp.2021.01.037_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clnesp.2021.01.037_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1590\/S0037-86822009000600002","article-title":"Chagas' disease and ageing: the coexistence of other chronic diseases with Chagas' disease in elderly patients","volume":"42","author":"Alves","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"10.1016\/j.clnesp.2021.01.037_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.clnesp.2021.01.037_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4103\/ijo.IJO_411_17","article-title":"A\u00a0tiny tick can cause a big health problem","volume":"65","author":"John","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.01.037_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar3865","article-title":"Current treatment of hepatitis C-associated rheumatic diseases","volume":"14","author":"Ferri","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.clnesp.2021.01.037_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/rheumatology\/36.9.981","article-title":"Fibromyalgia-associated hepatitis C virus infection","volume":"36","author":"Rivera","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"11","key":"10.1016\/j.clnesp.2021.01.037_bib7","first-page":"2300","article-title":"Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I","volume":"33","author":"Cruz","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.01.037_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.berh.2015.04.019","article-title":"Evolving spectrum of HIV-associated rheumatic syndromes","volume":"29","author":"Fox","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.01.037_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/sarh.2000.16527","article-title":"The changing spectrum of rheumatic disease in human immunodeficiency virus infection","volume":"30","author":"Reveille","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.clnesp.2021.01.037_bib10","first-page":"804","article-title":"The prevalence of fibromyalgia among patients with hepatitis B virus infection","volume":"6","author":"Ozsahin","year":"2013","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"10.1016\/j.clnesp.2021.01.037_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/39.11.1272","article-title":"Prolonged arthritis associated with sindbis-related (Pogosta) virus infection","volume":"39","author":"Laine","year":"2000","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.clnesp.2021.01.037_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archinte.159.8.865","article-title":"A\u00a0prospective study of tender points and fibromyalgia during and after an acute viral infection","volume":"159","author":"Rea","year":"1999","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.clnesp.2021.01.037_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-117-4-281","article-title":"Lyme disease associated with fibromyalgia","volume":"117","author":"Dinerman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clnesp.2021.01.037_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00296-003-0355-7","article-title":"Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes","volume":"23","author":"Endresen","year":"2003","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.clnesp.2021.01.037_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-008-1044-4","article-title":"Seroprevalence of parvovirus B19 in fibromyalgia syndrome","volume":"28","author":"Buyukkose","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.01.037_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-010-1618-9","article-title":"Helicobacter pylori seropositivity in fibromyalgia syndrome","volume":"30","author":"Akkaya","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.01.037_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s13365-018-0703-8","article-title":"The role of HHV-6 and HHV-7 infections in the development of fibromyalgia","volume":"25","author":"Krumins","year":"2019","journal-title":"J\u00a0Neurovirol"},{"issue":"10","key":"10.1016\/j.clnesp.2021.01.037_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/rheumatology\/36.10.1134a","article-title":"Chlamydia pneumoniae antibodies in myalgia of unknown cause (including fibromyalgia)","volume":"36","author":"Machtey","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"6 Suppl.\u00a069","key":"10.1016\/j.clnesp.2021.01.037_bib19","first-page":"S118","article-title":"Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations?","volume":"29","author":"Cassisi","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.01.037_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1573397111666150619094420","article-title":"A\u00a0historical and clinical perspective endorsing person-centered management of fibromyalgia syndrome","volume":"11","author":"Masi","year":"2015","journal-title":"Curr Rheumatol Rev"},{"issue":"8","key":"10.1016\/j.clnesp.2021.01.037_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.apmr.2016.01.026","article-title":"Swimming improves pain and Functional capacity of patients with fibromyalgia: a randomized controlled trial","volume":"97","author":"Fernandes","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clnesp.2021.01.037_bib22","first-page":"2915","article-title":"Impact of daily yoga-based exercise on pain, catastrophizing, and sleep amongst individuals with fibromyalgia","volume":"12","author":"Lazaridou","year":"2019","journal-title":"J\u00a0Pain Res"},{"issue":"12","key":"10.1016\/j.clnesp.2021.01.037_bib23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.apmr.2009.06.021","article-title":"Effect of pilates training on people with fibromyalgia syndrome: a pilot study","volume":"90","author":"Altan","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"10.1016\/j.clnesp.2021.01.037_bib24","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/j.pain.0000000000001036","article-title":"Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial","volume":"158","author":"Lumley","year":"2017","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.clnesp.2021.01.037_bib25","first-page":"379","article-title":"Vitamin D supplementation seems to improve fibromyalgia symptoms: preliminary results","volume":"20","author":"De Carvalho","year":"2018","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clnesp.2021.01.037_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12891-020-03201-9","article-title":"Determining the association between fibromyalgia, the gut microbiome and its biomarkers: a systematic review","volume":"21","author":"Erdrich","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clnesp.2021.01.037_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2015","article-title":"Mapping of host-parasite-microbiome interactions reveals metabolic determinants of tropism and tolerance in Chagas disease","volume":"6","author":"Hossain","year":"2020","journal-title":"Sci Adv"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:57:15Z","timestamp":1762498635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457721000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"alternative-id":["S2405457721000516"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.01.037","relation":{},"ISSN":["2405-4577"],"issn-type":[{"type":"print","value":"2405-4577"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibromyalgia associated with Chagas' disease treated with nutraceuticals","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}